{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:25:08Z","timestamp":1772022308052,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010215","name":"Deutsche Diabetes Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010215","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003107","name":"Bundesministerium f\u00fcr Gesundheit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.atherosclerosis.2020.01.030","type":"journal-article","created":{"date-parts":[[2020,3,8]],"date-time":"2020-03-08T22:29:16Z","timestamp":1583706556000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Serum uromodulin and risk for cardiovascular morbidity and mortality in the community-based KORA F4 study"],"prefix":"10.1016","volume":"297","author":[{"given":"Cornelia","family":"Then","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger L.","family":"Then","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Lechner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Thorand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa","family":"Meisinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margit","family":"Heier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Rathmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Scherberich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Seissler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.kint.2016.09.015","article-title":"Cardiovascular events and death in Japanese patients with chronic kidney disease","volume":"91","author":"Tanaka","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz392","article-title":"Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial","author":"Garimella","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib3","article-title":"Plasma uromodulin correlates with kidney function and identifies early stages in chronic kidney disease patients","volume":"95","author":"Steubl","year":"2016","journal-title":"Med. (United States)."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib4","series-title":"Nephrol. Dial. Transplant","first-page":"284","article-title":"Serum uromodulin-a marker of kidney function and renal parenchymal integrity","author":"Scherberich","year":"2018"},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrneph.2017.101","article-title":"Uromodulin: from physiology to rare and complex kidney disorders","volume":"13","author":"Devuyst","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1523-1755.2004.00452.x","article-title":"Tamm-Horsfall protein knockout mice are more prone to urinary tract infection","volume":"65","author":"Bates","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib7","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1523-1755.2004.00867.x","article-title":"Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation","volume":"66","author":"Mo","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib8","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1128\/IAI.70.5.2650-2656.2002","article-title":"Polarized expression of Tamm-Horsfall protein by renal tubular epithelial cells activates human granulocytes","volume":"70","author":"Kreft","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2362.2005.01483.x","article-title":"Tamm-Horsfall protein: a multilayered defence molecule against urinary tract infection","volume":"35","author":"S\u00e4emann","year":"2005","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib10","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1681\/ASN.2012040338","article-title":"Uromodulin triggers IL-1\u03b2-dependent innate immunity via the NLRP3 inflammasome","volume":"23","author":"Darisipudi","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib11","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1152\/ajprenal.00543.2012","article-title":"Tamm-Horsfall protein translocates to the basolateral domain of thick ascending limbs, interstitium, and circulation during recovery from acute kidney injury","volume":"304","author":"El-Achkar","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijcard.2016.12.183","article-title":"Serum uromodulin is a predictive biomarker for cardiovascular events and overall mortality in coronary patients","volume":"231","author":"Leiherer","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib13","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1681\/ASN.2016111162","article-title":"Serum uromodulin and mortality risk in patients undergoing coronary angiography","volume":"28","author":"Delgado","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib14","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1210\/jc.2018-02557","article-title":"Serum uromodulin is associated with but does not predict type 2 diabetes in elderly KORA F4\/FF4 study participants","volume":"104","author":"Then","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib15","article-title":"Serum uromodulin is associated with impaired glucose metabolism","volume":"96","author":"Leiherer","year":"2017","journal-title":"Med. (United States)."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib16","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1530\/EC-19-0352","article-title":"Serum uromodulin is inversely associated with the metabolic syndrome in the KORA f4 study","volume":"8","author":"Then","year":"2019","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib17","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/ndt\/gfy056","article-title":"Factors associating with differences in the incidence of renal replacement therapy among elderly: data from the ERA-EDTA Registry","volume":"33","author":"Helve","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib18","doi-asserted-by":"crossref","DOI":"10.1055\/s-2005-858235","article-title":"KORA - a research platform for population based health research","volume":"67","author":"Holle","year":"2005","journal-title":"Gesundheitswesen"},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib19","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1464-5491.2009.02863.x","article-title":"Incidence of Type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4\/F4 cohort study","volume":"26","author":"Rathmann","year":"2009","journal-title":"Diabet. Med."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib20","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.2337\/dc11-0118","article-title":"Retinol-binding protein 4 is associated with prediabetes in adults from the general population: the cooperative health research in the Region of Augsburg (KORA) F4 study","volume":"34","author":"Meisinger","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib21","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1530\/EJE-12-0472","article-title":"Vasoregulatory peptides pro-endothelin-1 and pro-adrenomedullin are associated with metabolic syndrome in the population-based KORA F4 study","volume":"167","author":"Seissler","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib23","article-title":"Association of serum uromodulin with mortality and cardiovascular disease in the elderly\u2014the Cardiovascular Health Study","author":"Steubl","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib24","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/HYPERTENSIONAHA.113.01423","article-title":"Validation of uromodulin as a candidate gene for human essential hypertension","volume":"63","author":"Graham","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib25","first-page":"131","article-title":"Identification of the scavenger receptors SREC-I, Cla-1 (SR-BI), and SR-AI as cellular receptors for Tamm-Horsfall protein","volume":"83","author":"Majdic","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib26","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1172\/JCI200522720","article-title":"Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism","volume":"115","author":"S\u00e4emann","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib27","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ki.1993.343","article-title":"Tamm-Horsfall glycoprotein binds IgG with high affinity","volume":"44","author":"Rhodes","year":"1993","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib28","first-page":"474","article-title":"Binding of Tamm-Horsfall protein to complement 1q measured by ELISA and resonant mirror biosensor techniques under various ionic-strength conditions","volume":"78","author":"Rhodes","year":"2000","journal-title":"Immunol. Cell Biol."},{"issue":"80","key":"10.1016\/j.atherosclerosis.2020.01.030_bib29","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1126\/science.3498215","article-title":"Uromodulin (Tamm-Horsfall glycoprotein): a renal ligand for lymphokines","volume":"237","author":"Hession","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib30","article-title":"Tamm\u2013Horsfall protein is a potent immunomodulatory molecule and a disease biomarker in the urinary system","volume":"23","author":"Wu","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib31","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1016\/S0024-3205(99)00527-5","article-title":"The dynamic responses of pro-inflammatory and anti-inflammatory cytokines of human mononuclear cells induced by uromodulin","volume":"65","author":"Su","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw3639","article-title":"Circulating uromodulin inhibits systemic oxidative stress by inactivating the TRPM2 channel","volume":"11","author":"LaFavers","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib33","article-title":"Tamm-Horsfall protein\/uromodulin deficiency elicits tubular compensatory responses leading to hypertension and hyperuricemia","author":"Liu","year":"2018","journal-title":"Am. J. Physiol. Physiol."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib34","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/HYPERTENSIONAHA.114.03132","article-title":"Uromodulin, an emerging novel pathway for blood pressure regulation and hypertension","volume":"64","author":"Padmanabhan","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ki.2013.63","article-title":"Uromodulin upregulates TRPV5 by impairing caveolin-mediated endocytosis","volume":"84","author":"Wolf","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib36","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/nm.3384","article-title":"Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression","volume":"19","author":"Citterio","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2020.01.030_bib37","doi-asserted-by":"crossref","first-page":"21928","DOI":"10.1074\/jbc.M001534200","article-title":"Pregnancy-associated changes in the glycosylation of tamm-horsfall glycoprotein: expression of sialyl lewis sequences on core 2 type o-glycans derived from uromodulin","volume":"275","author":"Easton","year":"2000","journal-title":"J. Biol. Chem."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915020300721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915020300721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:43:33Z","timestamp":1758156213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915020300721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":37,"alternative-id":["S0021915020300721"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.01.030","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum uromodulin and risk for cardiovascular morbidity and mortality in the community-based KORA F4 study","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}